Herpes Zoster Infection as an Adverse Reaction to Treatments for Ulcerative Colitis: A Review of Reports to the FDA Adverse Events Reporting System (FAERS)

Remicade (infliximab) - J&J

balsalazide - Generic mfg.

Cimzia (certolizumab pegol) - Astellas, UCB

Dipentum (olsalazine sodium) - Viatris, UCB

Humira (adalimumab) - AbbVie

Tremfya (guselkumab) - J&J

Omvoh (mirikizumab-mrkz) - Eli Lilly

tofacitinib - Generic mfg.

methotrexate - Generic mfg.

sulfasalazine - Generic mfg.

Stelara (ustekinumab) - J&J

Skyrizi (risankizumab-rzaa) - AbbVie, Boehringer Ingelheim

Simponi (golimumab) - J&J

Rinvoq (upadacitinib) - AbbVie

mercaptopurine - Generic mfg.

Entyvio (vedolizumab) - Takeda

Zeposia (ozanimod) - BMS

Velsipity (etrasimod) - Pfizer

azathioprine - Generic mfg.

Nick Adimi MD 1; Ethan Anderson DO 2; Bilal Ahmed DO 2; Eli Ehrenpreis MD FACG 2

Aug 29, 2026